Market Pulse Archives

June 27, 2022, 6:18 a.m. EDT

Coronavirus tally: Pfizer says updated COVID-19 booster is better against omicron, as cases top 100,000 again

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.35% and BioNTech SE /zigman2/quotes/214419716/composite BNTX +0.25% said over the weekend that the change they made to their COVID-19 vaccine that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order a formula change for vaccines in hopes that the modified vaccines could protect against another COVID-19 surge that is expected in the fall and the winter. The seven-day average of new daily COVID-19 cases was 102,818 on Sunday, the third-straight day above the 100,000 mark, and up 14% from two weeks ago, according to a New York Times Tracker . The daily average of hospitalizations rose to 31,591, up 6% form two weeks ago and the most since March 9, while daily deaths increased 5% from two weeks ago to 348.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 49.61
-0.18 -0.35%
Volume: 2.20M
Aug. 10, 2022 10:14a
P/E Ratio
11.43
Dividend Yield
3.21%
Market Cap
$279.31 billion
Rev. per Employee
$1.17M
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 157.60
+0.39 +0.25%
Volume: 207,323
Aug. 10, 2022 10:14a
P/E Ratio
3.03
Dividend Yield
0.00%
Market Cap
$38.15 billion
Rev. per Employee
$7.28M
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.